Daniel Janse

Arbor Biotechnologies has appointed Daniel Janse as chief business officer. Janse most recently served as senior director of business development at Juno Therapeutics, and has held leadership positions at Johnson & Johnson, Inventages Venture Capital, Cell Therapy, McKinsey, and the Novartis Institutes for Biomedical Research.